Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
Figure 2
ATO treatment (2.5 µM) induces limited apoptosis in breast cancer cells.
Untreated cells (top panel) and cells treated with ATO (bottom panel) were then analyzed by staining with PI and annexin V, followed by flow cytometry. The proportion of cells in apoptosis is shown in the figure.